JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eto, K.
Right arrow Articles by Kadowaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eto, K.
Right arrow Articles by Kadowaki, T.

J Biol Chem, Vol. 274, Issue 36, 25386-25392, September 3, 1999


NADH Shuttle System Regulates KATP Channel-dependent Pathway and Steps Distal to Cytosolic Ca2+ Concentration Elevation in Glucose-induced Insulin Secretion*

Kazuhiro EtoDagger , Sechiko Suga§, Makoto Wakui§, Yoshiharu TsubamotoDagger , Yasuo TerauchiDagger , Junko TakaDagger , Shinichi Aizawa, Mitsuhiko NodaDagger , Satoshi KimuraDagger , Haruo Kasaiparallel , and Takashi KadowakiDagger **

From the Dagger  Department of Metabolic Diseases and parallel  Department of Physiology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan, § Department of Physiology, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan, and  Department of Morphogenesis, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, 4-24-1 Kuhonji, Kumamoto 862, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The NADH shuttle system is composed of the glycerol phosphate and malate-aspartate shuttles. We generated mice that lack mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), a rate-limiting enzyme of the glycerol phosphate shuttle. Application of aminooxyacetate, an inhibitor of the malate-aspartate shuttle, to mGPDH-deficient islets demonstrated that the NADH shuttle system was essential for coupling glycolysis with activation of mitochondrial ATP generation to trigger glucose-induced insulin secretion.

The present study revealed that blocking the NADH shuttle system severely suppressed closure of the ATP-sensitive potassium (KATP) channel and depolarization of the plasma membrane in response to glucose in beta  cells, although properties of the KATP channel on the excised beta  cell membrane were unaffected. In mGPDH-deficient islets treated with aminooxyacetate, Ca2+ influx through the plasma membrane induced by a depolarizing concentration of KCl in the presence of the KATP channel opener diazoxide restored insulin secretion. However, the level of the secretion was only ~40% of wild-type controls. Thus, glucose metabolism through the NADH shuttle system leading to efficient ATP generation is pivotal to activation of both the KATP channel-dependent pathway and steps distal to an elevation of cytosolic Ca2+ concentration in glucose-induced insulin secretion.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In pancreatic beta  cells, glucose metabolism in glycolysis and in mitochondria is pivotal to glucose-induced insulin secretion. Thus, mutations in the glucokinase gene (1, 2) and mitochondrial DNA (3) can cause type 2 diabetes mellitus, which is characterized by insufficient insulin secretion in response to glucose. Moreover, abrogation of beta  cell-specific glucokinase in mice (4, 5) and mitochondrial DNA in insulinoma cell lines (6-9) was associated with defective insulin secretion in response to glucose. The following cascade has been generally accepted as the glucose-induced insulin secretory pathway (10-13). Glucose-stimulated increase in cytosolic ATP or in the ratio of ATP to ADP closes ATP-sensitive potassium (KATP)1 channels, which depolarizes the plasma membrane potential above a threshold, leading to Ca2+ entry into the cytosol through activation of voltage-dependent Ca2+ channels (VDCCs). The rise in cytosolic Ca2+ concentration ([Ca2+]c) is thought to finally trigger exocytosis of insulin from secretory vesicles.

It has been known that pyruvate, an end product of aerobic glycolysis, cannot stimulate insulin secretion although it is oxidized as efficiently as glucose in beta  cells (14, 15). Studies with an inhibitor of pyruvate transport into mitochondria or an inhibitor of the tricarboxylic acid cycle suggested that metabolism of glucose-derived pyruvate in mitochondria or in the tricarboxylic acid cycle was not well correlated with glucose-induced insulin secretion (16, 17). These results suggested that glycolysis-derived factor(s) other than pyruvate are required for activation of mitochondrial metabolism and for generation of the metabolic signals such as ATP. NADH, which is generated at a step catalyzed by a glycolytic enzyme glyceraldehyde-3 phosphate dehydrogenase, is one such candidate. This is because the electrons of the cytosolic NADH are transferred into the mitochondrial electron transfer chain directly through the NADH shuttle system and enhance the mitochondrial membrane potential. There are two known NADH shuttles, the glycerol phosphate shuttle and malate-aspartate shuttle (18, 19). Recently, we have generated mice that lack mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH), a rate-limiting enzyme of the glycerol phosphate shuttle (20). When aminooxyacetate (AOA), a well characterized inhibitor of aspartate aminotransferases in the malate-aspartate shuttle (19, 21-23), was applied to mGPDH-deficient islets, glucose-induced increases in glucose oxidation at the tricarboxylic acid cycle, production of NAD(P)H autofluorescence, hyperpolarization of mitochondrial membrane potential, calcium influx into mitochondria, and cellular ATP content were severely impaired, and insulin secretion was completely abrogated (20). These results demonstrated that the NADH shuttle system is essential for coupling glycolysis with mitochondrial ATP generation to trigger glucose-induced insulin secretion.

However, the mechanism by which deprivation of cellular ATP led to the downstream events that culminated in abrogation of insulin secretion was not addressed in the previous study. Under the conditions where the NADH shuttle system was stopped, the change in [Ca2+]c in response to glucose was significantly impaired. An initial drop below a base line and the first phase peak of [Ca2+]c failed to occur, although it was followed by a gradual elevation of [Ca2+]c to the second phase plateau level in 10 to 15 min (20). These results suggested that Ca2+ uptake of endoplasmic reticulum by Ca2+-ATPase and Ca2+ influx through VDCCs from the extracellular compartment were severely impaired (24-26). In beta  cells, the activity of VDCCs is controlled by the plasma membrane potential, which in turn is mainly regulated by the activity of the KATP channel (27-29). Thus, we hypothesized that glucose metabolism without the functional NADH shuttle system was not sufficient to close the KATP channel due to inefficient generation of ATP and to elicit depolarization of the plasma membrane and generation of action potentials. Moreover, steps distal to an elevation of [Ca2+]c are also energy-requiring (30-33). These steps including mobilization of secretory granules toward the plasma membrane, priming of the granules, and a final fusion process may also have been affected. In this article, using electrophysiological techniques we provide evidence that glucose metabolism through the NADH shuttle system is essential to regulate the KATP channel-dependent pathway in glucose-induced insulin secretion. In addition, with diazoxide and a depolarizing concentration of KCl we show that steps distal to an elevation of [Ca2+]c are also regulated by glucose metabolism through the system.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Islet Isolation and beta  Cell Preparation-- Isolation of islets from mGPDH-deficient mice (20) and their wild-type littermates was carried out as described previously (34). In brief, after clamping the common bile duct at a point close to the duodenum outlet, 2.5 ml of Krebs-Ringer bicarbonate buffer (118.4 mM NaCl, 4.7 mM KCl, 1.3 mM MgSO4, 1.2 mM KH2PO4, 2.0 mM CaCl2, 10 mM NaHCO3, and 10 mM HEPES at pH 7.4) containing collagenase (Sigma) was injected into the duct. The swollen pancreas was taken out and incubated at 37 °C for 3 min. The pancreas was dispersed by pipetting and washed two times with Krebs-Ringer bicarbonate buffer. Islets were collected by manual picking and incubated in RPMI medium (Life Technologies, Inc.) supplemented with 100 units/ml penicillin, 100 µg/ml streptomycin, and 10% fetal calf serum. Isolation of single beta  cells was performed using 1000 units/ml dispase (Godo Shusei, Japan), as described previously (35).

Analysis of Insulin Secretion-- Insulin secretion from islets was measured with Krebs-Ringer bicarbonate buffer with a basal glucose concentration of 2.8 mM unless otherwise stated. Batch incubation was performed with 10 islets/tube at 37 °C for 1 h after preincubation with the basal glucose concentration for 20 min. Perifusion experiments were performed with 30 islets/chamber at 37 °C with a flow rate of 0.6 ml. AOA, when used, was added to both preincubation and incubation medium. AOA and diazoxide were purchased from Sigma.

Measurement of [Ca2+]c-- A single islet was placed under a microscope (IMT-2, Olympus, Japan) and perifused with Sol II buffer containing 150 mM NaCl, 5 mM KCl, 1.0 mM MgCl2, 2.0 mM CaCl2, and 10 mM HEPES (pH 7.4) at 37 °C. Fluorescence was excited with light emitted from a xenon lamp (TILL Photonics, Germany), collected through interference filters (Olympus, Japan), and detected using a photomultiplier (NT5783, Hamamatsu Photonics, Japan). Islets were loaded with 15 µM fura-2/acetoxymethylester (Molecular Probes, Eugene, OR) at 37 °C for 1 h. The fluorescence was excited with a dual-wavelength ratiometric mode at 340 and 380 nm. The emission wavelength was filtered at 500 nm.

Electrical Recordings-- Dispersed islet cells were kept in a 35-mm Petri dish on an inverted microscope. Identification of beta  cells from other islet cells was carried out by detecting the excitatory electrical response of the cells to 15 mM glucose or to 0.5 mM tolbutamide. The patch clamp method was used to record membrane currents and membrane potential with an EPC-7 patch-clamp amplifier (List Electronic, Germany) (36, 37). The resistance of electrodes made of borosillicate glass capillaries was 2-4 megaohms. For recording the plasma membrane potential, the nystatin-perforated whole-cell configuration was used (38, 39). For recording the whole-cell membrane currents, the conventional whole-cell mode was used. The membrane capacitance ranged from 12 to 20 picofarads. The membrane potential was repeatedly changed from -90 to -50 mV by ramp pulses with a ramp pulse generator (SET-2100, Nihon Kohden, Japan). Both the rising and falling time of each ramp pulse was 2 s in duration. In the inside-out mode, single channel currents were recorded. The data were analyzed by using a single channel current analysis program (QP-129J, Nihon Kohden). All experiments were performed at room temperature. The standard extracellular solution contained 130 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 1 mM CaCl2, 2 mM glucose, and 10 mM HEPES (pH 7.3). When the cells were stimulated with glucose, sucrose was added to the control solution to adjust the osmolarity. In the nystatin-perforation recordings, the pipette solution contained 135 mM KCl, 1.2 mM MgCl2, 0.5 mM EGTA, 200 µg/ml nystatin (Sigma), and 10 mM HEPES (pH 7.3). In the conventional whole-cell recordings, the pipette solution contained 100 mM potassium gluconate, 35 mM KCl, 1.2 mM MgCl2, 0.5 mM EGTA, 1 mM Na2ATP, 1 mM GTP, 2 mM glucose, and 10 mM HEPES (pH 7.2). In single channel recordings, both pipette (external) and internal solutions contained 135 mM KCl, 1.2 mM MgCl2, 0.5 mM EGTA, 5 mM tetraethylammonium chloride (Sigma), 10 mM glucose, and 10 mM HEPES. The pH was 7.3 in the external solution and 7.2 in the internal solution. Cells in the bath were superfused with a stream of an extracellular solution. Drugs were dissolved in the extracellular solution and applied to cells by switching flow tubes.

Measurement of Islet ATP Content-- Ten islets were incubated with Krebs-Ringer bicarbonate buffer containing 2.8, 10.0, or 16.7 mM glucose at 37 °C for 1 h. After aspiration of medium, the metabolism was snap-stopped by an addition of ice-cold 1 N perchloric acid and freezing with liquid nitrogen. Then, samples were thawed, sonicated, and neutralized with NaOH (40). ATP content was measured using a luciferase-luciferin system (Sigma).

Statistical Analysis-- Data were expressed as means ± S.E. Statistical significance was evaluated with the Student's t test or by analysis of variance.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Effect of AOA on Glucose-responsive Changes in Insulin Secretion and [Ca2+]c in mGPDH-deficient Islets-- In static incubation for 1 h, the increase in insulin secretion stimulated by 16.7 mM glucose was inhibited by 94% in mGPDH-deficient mice islets treated with 5 mM AOA (0.11 ± 0.03 ng/islet/h) compared with wild-type islets without AOA (1.83 ± 0.19 ng/islet/h). Perifusion experiments revealed that the first phase of the secretion was severely decreased and the second phase was totally abrogated (Fig. 1A, closed squares) compared with wild-type islets without AOA (Fig. 1A, closed circles). The inhibitory effect of AOA on glucose-induced insulin secretion from mGPDH-deficient islets was dose-dependent, and the half-maximal inhibitory concentration of AOA was ~1 mM at 16.7 mM glucose (Fig. 1B). As previously reported (20), an initial small drop and the first phase peak of [Ca2+]c, which were normally observed in wild-type islets without AOA in response to 22.2 mM glucose (Fig. 1C, left panel), disappeared when 5 mM AOA was applied to mGPDH-deficient islets (Fig. 1C, right panel). However, [Ca2+]c gradually rose in 10 to 15 min to the second phase plateau level, which was comparable to that of wild-type islets without AOA. At 1 mM AOA, the initial drop and the subsequent first phase peak of [Ca2+]c remained missing, whereas the second phase plateau was reached in 6 to 8 min (data not shown). These results suggested that both the appearance of the first phase peak of [Ca2+]c and the time required to raise [Ca2+]c to the second phase level were dependent on glucose metabolism through the NADH shuttle system and that loss of function of the shuttle system impaired Ca2+ influx into the cytosol. Stimulation by 15 mM glucose instead of 16.7 or 22.2 mM glucose produced essentially similar results to the above experiments.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of AOA on glucose-induced insulin secretion and change in [Ca2+]c in mGPDH-deficient islets. A, glucose-induced insulin secretion from wild-type islets (closed circles, n = 4) and from mGPDH-deficient islets treated with 5 mM AOA (closed squares, n = 4). Glucose (G) concentration was raised from 2.8 to 16.7 mM at 0 min in perifusion experiments. B, dose-dependent inhibition by AOA of 16.7 mM glucose-induced insulin secretion from mGPDH-deficient islets. The islets were incubated in the presence of 0, 0.5, 0.75, 1.0, 2.0, 3.0, or 5.0 mM AOA for 1 h (n = 4). C, glucose-induced changes in [Ca2+]c. Wild-type (WT) islets (left panel) or mGPDH-deficient islets treated with 5 mM AOA (right panel) were challenged by 22.2 mM glucose, and changes in [Ca2+]c were monitored with fura-2 fluorescence. Representative traces shown are from at least four experiments.

Effect of AOA on the Membrane Potential in mGPDH-deficient beta  Cells-- We next directly measured the plasma membrane potential of beta  cells with patch clamp techniques. Under the nystatin-perforated whole-cell mode, the resting membrane potentials in the presence of 2 mM glucose were -58.4 ± 1.3 mV (n = 24) in wild-type beta  cells, -61.5 ± 1.6 mV (n = 24) in wild-type beta  cells with 5 mM AOA, -61.3 ± 1.9 mV (n = 23) in mGPDH-deficient beta  cells, and -62.5 ± 1.7 mV (n = 22) in mGPDH-deficient beta  cells with 5 mM AOA. There were no significant differences among the four groups. In wild-type beta  cells treated with 5 mM AOA, stimulation by 15 mM glucose normally depolarized the plasma membrane potential to ~50 mV in 70-90 s, where action potentials were generated (Fig. 2A). These normal responses were also observed in mGPDH-deficient beta  cells without AOA (Fig. 2B). However, in mGPDH-deficient beta  cells treated with 5 mM AOA, the membrane potential was only minimally depolarized in response to 15 mM glucose and failed to reach the threshold and to generate action potentials within the measurement period of 4 min (Fig. 2C).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Measurement of the plasma membrane potential of beta  cells in a nystatin-perforated whole-cell mode. Glucose concentration was raised from 2 to 15 mM at indicated points. A, wild-type (WT) beta  cell treated with 5 mM AOA. B, mGPDH-deficient beta  cell. C, mGPDH-deficient beta  cell treated with 5 mM AOA. D, mGPDH-deficient beta  cells treated with 5 mM AOA. Tolbutamide (0.5 mM) was applied to the cell as indicated after glucose stimulation. E, the plasma membrane potential was monitored for 15 min after 15 mM glucose stimulation in mGPDH-deficient beta  cell treated with 5 mM AOA. The electrical activity was observed 6 min after glucose stimulation in this trace. Representative traces shown are from at least six experiments.

Application of 0.5 mM tolbutamide to extracellular solution caused the depolarization of the plasma membrane and generated action potentials even in mGPDH-deficient beta  cells treated with AOA (Fig. 2D). This suggested that sensitivity of the KATP channel to sulfonylurea was preserved under these conditions.

Because the second phase plateau of [Ca2+]c was attained within 10 to 15 min after glucose stimulation in mGPDH-deficient islets treated with 5 mM AOA (Fig. 1C, right panel), we presumed that the membrane potential of beta  cells might take longer to reach the threshold. The measurement period was then extended to 15 min. Under these conditions, membrane depolarization and generation of action potentials were observed in 2 of 6 experiments; one at 6 min (Fig. 2E), and the other at 7 min after the glucose stimulation. Thus, small number of mGPDH-deficient beta  cells treated with AOA retained electrical excitability to glucose stimulation, although the initiation of the response was markedly delayed.

Effect of AOA on the KATP Channel Current in mGPDH-deficient beta  Cells-- We then studied the KATP channel current in response to glucose in a conventional whole-cell mode. Ramp voltage pulses from -90 mV to -50 mV were given every 4 s. In mGPDH-deficient beta  cells, the KATP channel current in response to the 40-mV voltage pulse was decreased from ~40 to ~15 pA by elevation of the extracellular glucose concentration from 2 to 15 mM (Fig. 3A, upper panel). At several time points during the trace, the mode of recording was transiently changed to a current clamp mode, where a stepwise depolarization of the membrane potential culminating in the generation of action potentials was clearly observed (Fig. 3A, lower panel). However, in mGPDH-deficient beta  cells treated with 5 mM AOA, no decrease in the KATP channel current (Fig. 3B, upper panel) or depolarization of the membrane potential (Fig. 3B, lower panel) in response to 15 mM glucose was observed. In contrast, application of 0.5 mM tolbutamide to the cells reversibly abolished the KATP channel current (Fig. 3B, lower panel).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   Measurement of the KATP channel current in beta  cells in a conventional whole-cell mode. The KATP channel current (I) and applied voltage (V) were shown. Glucose concentration was raised from 2 to 15 mM at indicated points. The clamp mode was transiently changed to a current clamp mode to monitor the plasma membrane potential. A, wild-type (WT) beta  cell. B, mGPDH-deficient beta  cells treated with 5 mM AOA. Tolbutamide (0.5 mM) was applied to the cell as indicated. Representative traces shown are from at least four experiments.

Electrophysiological Characteristics of the KATP Channel on the Excised Plasma Membrane-- We then performed electrophysiological analyses of the KATP channel itself in an inside-out patch of the plasma membrane excised from beta  cells. At a recording voltage of -60 mV, the amplitude of the KATP channel current in mGPDH-deficient beta  cells was the same as in wild-type beta  cells (Fig. 4A). When the KATP channel currents were plotted against the recording voltage from -60 mV to 60 mV at an interval of 10 mV, the current-voltage relationship of mGPDH-deficient beta  cells essentially overlapped that of wild-type beta  cells, which show a weak inward rectification (Fig. 4B). The single KATP channel conductance of mGPDH-deficient beta  cells measured between -60 mV and 0 mV was 73.1 ± 3.8 picosiemens (n = 4) and was not different from that of wild-type beta  cells (72.7 ± 3.3 picosiemens, n = 4).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 4.   Measurement of electrophysiological characteristics of the KATP channel on the beta  cell membrane in an inside-out patch clamp mode. A, the KATP channel currents were recorded at -60 mV on the excised beta  cell membrane from wild-type (WT) islets (upper panel) and from mGPDH-deficient islets (lower panel). B, the current-voltage relationships of the KATP channel on the excised beta  cell membrane from wild-type islets (open circles, n = 4) and from mGPDH-deficient islets (open squares, n = 4) are shown.

Inhibition by ATP of the KATP Channel Current on the Excised Plasma Membrane-- We next studied the effect of ATP on the KATP channel activity in the inside-out mode with the recording voltage at -60 mV. When 1 mM ATP was applied to the cytoplasmic surface of mGPDH-deficient beta  cell plasma membranes, the KATP channel current was immediately and completely abolished (Fig. 5A). The channel open probabilities at 0.1, 1, 10, 100, and 1000 µM ATP in mGPDH-deficient beta  cells were not different from those in wild-type beta  cells (Fig. 5B). These values were well in accordance with the theoretical values calculated with the Hill equation (41) (Fig. 5B). Thus, the electrophysiological characteristics of the KATP channel and its sensitivity to ATP per se were normal in mGPDH-deficient beta  cells.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Sensitivity to ATP of the KATP channel on the beta  cell membrane. A, measurement of the KATP channel current on the excised membrane of mGPDH-deficient beta  cells. ATP (1 mM) was applied inside the patch membrane as indicated. B, the relative KATP channel open time. ATP (0.1, 1, 10, 100, or 1000 µM) was applied to wild-type beta  cell membrane (open circles, n = 6) and to mGPDH-deficient beta  cell membrane (open squares, n = 6). Theoretical curves for wild-type beta  cell (solid line) and mGPDH-deficient beta  cell (dotted line) were drawn according to a Hill equation; (G/G0)=1/(1 + ([ATP]/ki)h), where G is open time probability with ATP at each concentration, G0 is open time probability without ATP, [ATP] is concentration of ATP, ki is ATP concentration at which the inhibition is half maximal, and h is the Hill coefficient. For wild-type beta  cell membrane (n = 6), G0 = 0.20 ± 0.02, ki = 10.5 ± 1.6 µM, and h = 1.35 ± 0.05. For mGPDH-deficient beta  cell membrane (n = 6), G0 = 0.21 ± 0.02, ki = 9.5 ± 0.3 µM, and h = 1.38 ± 0.01.

Role of the NADH Shuttle System in Steps Distal to an Elevation of [Ca2+]c-- When both the NADH shuttles were stopped by treating mGPDH-deficient beta  cells with 5 mM AOA, the first phase peak of [Ca2+]c in response to glucose disappeared (Fig. 1C, right panel). Moreover, it took 10 to 15 min for [Ca2+]c to reach the second phase plateau. These findings indicated an impairment of Ca2+ influx through the plasma membrane during this period. We then postulated that a restoration of Ca2+ influx could recover insulin secretion. To test this, islets were treated with diazoxide, a KATP channel opener, to hold the KATP channel open in combination with a high concentration of KCl to depolarize the plasma membrane. Under these conditions, it has been shown that glucose does not further elevate [Ca2+]c but amplifies the actions of Ca2+ on the insulin-secreting processes (31, 32, 42, 43). With application of 30 mM KCl in the presence of 250 µM diazoxide, the insulin secretory response to glucose was indeed restored in mGPDH-deficient islets treated with 5 mM AOA (Fig. 6, A-C, closed squares). The amounts of secreted insulin were increased by elevating glucose concentration from 2.8 to 10.0 mM and to 16.7 mM. Insulin released by this treatment was, however, still ~60% lower than that observed in wild-type islets treated with 250 µM diazoxide and 30 mM KCl in the absence of AOA at each concentration of glucose (Fig. 6, A-C, closed circles).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 6.   KCl-induced insulin release from islets in the presence of diazoxide. Wild-type islets (closed circles, n = 4) and mGPDH-deficient islets treated with 5 mM AOA (closed squares, n = 4) were perifused in the presence of 250 µM diazoxide and 2.8 mM (A), 10.0 mM (B), or 16.7 mM (C) glucose throughout experiments. Depolarizing stimulation by 30 mM KCl was started at 0 min.

To evaluate glucose metabolism leading to ATP generation in islets, we measured the ATP content of islets after glucose stimulation for 1 h in the presence of 250 µM diazoxide and 30 mM KCl. At 2.8 mM glucose, the ATP content of mGPDH-deficient islets treated with 5 mM AOA was 10.5 ± 0.3 pmol/islet, which was not different from that of wild-type islets (10.1 ± 0.7 pmol/islet). However, the ATP contents of mGPDH-deficient islets treated with AOA were significantly less than those of wild-type islets at both 10.0 mM glucose (11.2 ± 0.2 versus 13.1 ± 0.6 pmol/islet, respectively, p < 0.01) and 16.7 mM glucose (12.0 ± 0.4 versus 15.4 ± 0.05 pmol/islet, respectively, p < 0.01) (Fig. 7). These results indicated that efficient ATP generation by glucose metabolism through the NADH shuttles was important in the steps distal to elevation of [Ca2+]c in glucose-induced insulin secretion. The ATP contents in wild-type islets incubated with diazoxide and KCl were comparable to those in wild-type islets incubated without diazoxide or KCl at 2.8, 10.0, and 16.7 mM glucose (data not shown).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Measurement of ATP content of islets stimulated by glucose in the presence of diazoxide and KCl. Wild-type islets (open bars) and mGPDH-deficient islets treated with 5 mM AOA (filled bars) were stimulated by 2.8, 10.0, or 16.7 mM glucose in the presence of 250 µM diazoxide and 30 mM KCl. After incubation for 1 h, the metabolism was snap-stopped, and the ATP content of islets was measured with a luciferase assay.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

This study is the first to provide direct evidence that the NADH shuttle system plays an essential role in regulating both the KATP channel-dependent pathway and steps distal to Ca2+ influx through the plasma membrane in glucose-induced insulin secretion. The KATP channels are a weak inward rectifier that are expressed in a wide variety of tissues including pancreatic beta  cells, cardiac myocytes, skeletal muscle, and brain, and serve to couple cellular metabolic state to electrical excitability (44). In beta  cells, the KATP channels are composed of the inward rectifier potassium channel (Kir) 6.2 (45) and the sulfonylurea receptor (SUR) 1, a member of the superfamily of ATP binding cassette proteins (46). Kir6.2 acts as the ATP-sensitive pore-forming subunit of the KATP channel complex (47, 48), whereas SUR1 has been identified as the regulatory subunit, which confers sensitivity to sulfonylureas, channel openers, and Mg2+ nucleotides (41, 49, 50). The single KATP channel kinetics (Fig. 4) and its sensitivity to ATP (Fig. 5) on the excised membrane of mGPDH-deficient beta  cells were preserved compared with wild-type beta  cells, clearly discounting the possibility that the channel activity itself was impaired secondarily to the absence of mGPDH. When mGPDH-deficient beta  cells were treated with AOA to stop the function of the NADH shuttle system, glucose-stimulated generation of ATP in mitochondria was severely decreased (20). The present study showed that under these conditions, glucose-stimulated closure of the KATP channel was severely impaired and subsequent membrane depolarization and generation of action potentials were scarcely observed. These results demonstrated that activation of mitochondrial glucose metabolism through the NADH shuttle system and the resultant increase in cellular ATP content were pivotal to closure of the KATP channel and initiation of the downstream events leading to insulin secretion.

The mGPDH-deficient beta  cells treated with AOA completely preserved the response to sulfonylurea with respect to the KATP channel current, the plasma membrane potential, and insulin secretion (Fig. 3B and 2D) (20). This was in contrast to the observation that the effects of sulfonylurea on Ca2+ influx and insulin secretion were impaired in insulinoma-derived beta  cells that were treated for days with ethidium bromide to eradicate mitochondrial DNA, thereby abolishing oxidative phosphorylation (8). This difference is presumably dependent upon whether glucose-stimulated ATP generation was maintained at ~25% of the normal state (20) or was almost completely nullified (8). Although the mechanism of decreased sensitivity of the KATP channel to the drug in the ATP-depleted state is unclear, it may involve decreased binding of sulfonylurea to the channel, alteration of the phosphorylation state of the channel, and defective function of accessory constituent(s) of the channel (8, 51, 52).

There was an evident dissociation between the elevation of [Ca2+]c (Fig. 1C, right panel) and the inhibition of insulin secretion (Fig. 1A, closed squares) when the NADH shuttle system was blocked in islets. First, it should be considered that steps distal to an elevation of [Ca2+]c such as mobilization of secretory granules toward the plasma membrane, energization of the granules, and a final fusion process have been shown to be ATP-requiring (30). Consistent with this notion, when inhibitors of oxidative phosphorylation were applied to beta  cells, a similar dissociation between [Ca2+]c increase and insulin secretion was observed (33). A marked dependence of insulin secretion on energy metabolism has also been postulated as the reason why insulin secretion was inhibited by cooling, although Ca2+ influx was only slightly affected by this treatment (53). Moreover, the omission of ATP from the cytosol resulted in 89% inhibition of exocytosis elicited by Ca2+ stimulation in permeabilized insulin-secreting cells (54). Recently, it has also been shown that a final step of Ca2+-stimulated exocytosis is dependent on post-priming actions of cytosolic ATP (55). Second, it should also be noted that the time course of the [Ca2+]c rise to the second phase plateau in islets was considerably disordered (Fig. 1C, right panel). Disappearance of the initial [Ca2+]c drop suggests that Ca2+-ATPase of the endoplasmic reticulum may not be able to sequester cytosolic Ca2+ due to insufficient supply of ATP (26, 56). Disappearance of the first phase peak of [Ca2+]c and delay of its elevation to the second phase level indicated that the closure of KATP channel and generation of action potentials were severely disturbed, which were confirmed in single beta  cells (Fig. 3B and 2C). Furthermore, we postulate that the elevation of [Ca2+]c may also be ascribed, at least in part, to diminished Ca2+ uptake from cytosol by mitochondria (20) and to diminished Ca2+ extrusion from cytosol by plasma membrane Ca2+-ATPase. Thus, the [Ca2+]c rise may not take place at the critical time and site for the exocytotic processes. Collectively, the reduction of ATP supply accompanied by the nonphysiological [Ca2+]c rise appears to be unable to induce insulin secretion.

An apparent difference was also observed in Ca2+ behavior in response to glucose between an islet and a single beta  cell. Glucose-induced elevation of [Ca2+]c to the second phase level did occur in all mGPDH-deficient islets treated with AOA, although it was considerably delayed. In contrast, glucose-induced generation of the action potentials, which reflects Ca2+ spikes, was observed in only a small portion of mGPDH-deficient beta  cells treated with AOA in the same time range. The beta  cells constituting an islet are heterogeneous with respect to glucose metabolism and glucose-induced insulin secretion (57, 58). Although it is not certain how Ca2+ behavior in individual beta  cells is manifested in [Ca2+]c change of an islet, it is possible that a small portion of beta  cells that preserved electrical excitability in response to glucose may transmit the signal to adjacent cells. Thus, the glucose-induced change in [Ca2+]c that we actually observed in an islet might be an integration of these localized electrical activities that took place at various time points after glucose stimulation.

Diazoxide, which directly and selectively opens the KATP channel without interfering with beta  cell metabolism (59, 60), did not affect glucose-stimulated ATP generation of islets in our study (Fig. 7). Because opening of the KATP channel by diazoxide holds the plasma membrane potential at a resting level, VDCCs are not activated in response to glucose. However, application of 30 mM KCl in the presence of diazoxide depolarizes the membrane, which is followed by Ca2+ influx through VDCCs and stimulation of insulin secretion. Under these conditions, glucose is still able to enhance insulin secretion dose-dependently without significant alteration in [Ca2+]c, which has been described as the KATP channel-independent Ca2+-dependent pathway of glucose-induced insulin secretion (31, 32). When glucose-induced insulin secretion was abolished by the inhibition of the NADH shuttle system, recovery of insulin secretion through the KATP channel-independent Ca2+-dependent pathway was observed, and the extent of recovery was dependent on glucose concentration. However, the secretion was less than that observed in the presence of the functional NADH shuttle system (Fig. 6). Under these conditions, the increase in cellular ATP content of islets in response to glucose was suppressed when the shuttle system was blocked (Fig. 7). In a comprehensive study to identify regulators of insulin secretion through the KATP channel-independent Ca2+-dependent pathway, adenine nucleotides emerged as the best candidate (61). Taken together, ATP generation by efficient glucose metabolism through the NADH shuttle system probably functions in the steps distal to [Ca2+]c elevation.

In conclusion, we have clarified the two mechanisms by which the shutdown of the NADH shuttle function abolished glucose-induced insulin secretion. The insufficient closure of the KATP channel due to the depletion of cellular ATP was followed by impairment of the depolarization of the plasma membrane and Ca2+ influx into beta  cells. In addition, steps distal to Ca2+ influx into the cytosol were also affected. These results demonstrate that mitochondrial metabolism through the NADH shuttle system plays a central role as a common regulator of both the KATP channel-dependent pathway leading to [Ca2+]c elevation and the pathway in which the elevated [Ca2+]c promotes exocytosis of insulin from secretory vesicles. Recently, it has been reported that various steps in glucose-induced insulin secretion are impaired in type 2 diabetes mellitus caused by mutations in the hepatocyte nuclear factor-1alpha gene (62, 63). Defects in generation or transport of glycolysis-derived NADH into mitochondria are implicated in the impaired insulin secretion (62). Genetic or acquired defects in the NADH shuttle system may therefore be candidates for the causes of type 2 diabetes mellitus.

    ACKNOWLEDGEMENT

We thank Hiroshi Chiyonobu for care of the mice.

    FOOTNOTES

* This work was supported by Grant-in-aid for Creative Basic Research 10NP0201 from the Ministry of Education, Science, Sports, and Culture, Japan (to T. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed. Tel.: 81-3-3815-5411 (ext. 33111); Fax: 81-3-5689-7209; E-mail: kadowaki-3im@h.u-tokyo.ac.jp.

    ABBREVIATIONS

The abbreviations used are: KATP, ATP-sensitive potassium; VDCC, voltage-dependent calcium channel; mGPDH, mitochondrial glycerol-3-phosphate dehydrogenase; AOA, aminooxyacetate; [Ca2+]c, cytosolic Ca2+ concentration; Kir, inward rectifier potassium channel; SUR, sulfonylurea receptor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Vionnet, N., Stoffel, M., Takeda, J., Yasuda, K., Bell, G. I., Zouali, H., Lesage, S., Velho, G., Iris, F., Passa, P., Froguel, P., and Cohen, D. (1992) Nature 356, 721-722[CrossRef][Medline] [Order article via Infotrieve]
2. Sakura, H., Eto, K., Kadowaki, H., Simokawa, K., Ueno, H., Koda, N., Fukushima, Y., Akanuma, Y., Yazaki, Y., and Kadowaki, T. (1992) J. Clin. Endocrinol. Metab. 75, 1571-1573[Abstract]
3. Kadowaki, T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe, Y., Sakura, H., Awata, T., Goto, Y., Hayakawa, T., Matuoka, K., Kawamori, R., Kamada, T., Horai, S., Nonaka, I., Hagura, R., Akanuma, Y., and Yazaki, Y. (1994) N. Engl. J. Med. 330, 962-968[Abstract/Free Full Text]
4. Grupe, A., Hultgren, B., Ryan, A., Ma, Y. H., Bauer, M., and Stewart, T. A. (1995) Cell 83, 69-78[CrossRef][Medline] [Order article via Infotrieve]
5. Terauchi, Y., Sakura, H., Yasuda, K., Iwamoto, K., Takahashi, N., Ito, K., Kasai, H., Suzuki, H., Ueda, O., Kamada, N., Jishage, K., Komeda, K., Noda, M., Kanazawa, Y., Taniguchi, S., Miwa, I., Akanuma, Y., Kodama, T., Yazaki, Y., and Kadowaki, T. (1995) J. Biol. Chem. 270, 30253-30256[Abstract/Free Full Text]
6. Soejima, A., Inoue, K., Takai, D., Kaneko, M., Ishihara, H., Oka, Y., and Hayashi, J. (1996) J. Biol. Chem. 271, 26194-26199[Abstract/Free Full Text]
7. Kennedy, E. D., Maechler, P., and Wollheim, C. B. (1998) Diabetes 47, 374-380[Abstract]
8. Tsuruzoe, K., Araki, E., Furukawa, N., Shirotani, T., Matsumoto, K., Kaneko, K., Motoshima, H., Yoshizato, K., Shirakami, A., Kishikawa, H., Miyazaki, J., and Shichiri, M. (1998) Diabetes 47, 621-631[Abstract]
9. Hayakawa, T., Noda, M., Yasuda, K., Yorifuji, H., Taniguchi, S., Miwa, I., Sakura, H., Terauchi, Y., Hayashi, J., Sharp, G. W. G., Kanazawa, Y., Akanuma, Y., Yazaki, Y., and Kadowaki, T. (1998) J. Biol. Chem. 273, 20300-20307[Abstract/Free Full Text]
10. Matschinsky, F. M. (1996) Diabetes 45, 223-241[Abstract]
11. Dukes, I. D., and Philipson, L. H. (1996) Diabetes 45, 845-853[Abstract]
12. Ashcroft, F. M., Proks, P., Smith, P. A., Ammala, C., Bokvist, K., and Rorsman, P. (1994) J. Cell. Biochem. 55 (suppl.), 54-65
13. Wollheim, C. B, and Pralong, W. F. (1990) Biochem. Soc. Trans. 18, 111-114[Medline] [Order article via Infotrieve]
14. Sener, A., Kawazu, S., Hutton, J. C., Boschero, A. C., Devis, G., Somers, G., Herchuelz, A., and Malaisse, W. J. (1978) Biochem. J. 176, 217-232[Medline] [Order article via Infotrieve]
15. Zawalich, W. S., and Zawalich, K. C. (1997) J. Biol. Chem. 272, 3527-3531[Abstract/Free Full Text]
16. Dukes, I. D., McIntyre, M. S., Mertz, R. J., Philipson, L. H., Roe, M. W., Spencer, B., and Worley, J. F., III (1994) J. Biol. Chem. 269, 10979-10982[Abstract/Free Full Text]
17. Mertz, R. J., Worley, J. F., III, Spencer, B., Johnson, J. H., and Dukes, I. D. (1996) J. Biol. Chem. 271, 4838-4845[Abstract/Free Full Text]
18. MacDonald, M. J. (1981) J. Biol. Chem. 256, 8287-8290[Abstract/Free Full Text]
19. MacDonald, M. J. (1982) Arch. Biochem. Biophys. 213, 643-649[CrossRef][Medline] [Order article via Infotrieve]
20. Eto, K., Tsubamoto, Y., Terauchi, Y., Sugiyama, T., Kishimoto, T., Takahashi, N., Yamauchi, N., Kubota, N., Murayama, S., Aizawa, T., Akanuma, Y., Aizawa, S., Kasai, H., Yazaki, Y., and Kadowaki, T. (1999) Science 283, 981-985[Abstract/Free Full Text]
21. Malaisse, W. J., Malaisse-Lagae, F., and Sener, A. (1982) Endocrinology 111, 392-397[Abstract]
22. Lebrun, P., Malaisse, W. J., and Herchuelz, A. (1983) Am. J. Physiol. 245, E38-E46[Abstract/Free Full Text]
23. Lebrun, P., Malaisse, W. J., and Herchuelz, A. (1984) Horm. Metabol. Res. 16, 322-324[Medline] [Order article via Infotrieve]
24. Wolf, B. A., Colca, J. R., Turk, J., Florholmen, J., and McDaniel, M. L. (1988) Am. J. Physiol. 254, E121-E136[Abstract/Free Full Text]
25. Henquin, J. C. (1987) Horm. Res. (Basel) 27, 168-178[Medline] [Order article via Infotrieve]
26. Roe, M. W., Philipson, L. H., Frangakis, C. J., Kuznetsov, A., Mertz, R. J., Lancaster, M. E., Spencer, B., Worley, J. F., III, and Dukes, I. D. (1994) J. Biol. Chem. 269, 18279-18282[Abstract/Free Full Text]
27. Atwater, I., Ribalet, B., and Rojas, E. (1978) J. Physiol. 278, 117-139 [Abstract/Free Full Text]
28. Cook, D. L., and Hales, C. N. (1984) Nature 311, 271-273[CrossRef][Medline] [Order article via Infotrieve]
29. Ashcroft, F. M., Harrison, D. E., and Ashcroft, S. J. (1984) Nature 312, 446-448[CrossRef][Medline] [Order article via Infotrieve]
30. Rorsman, P. (1997) Diabetologia 40, 487-495[CrossRef][Medline] [Order article via Infotrieve]
31. Gembal, M., Gilon, P., and Henquin, J. C. (1992) J. Clin. Invest. 89, 1288-1295
32. Sato, Y., Aizawa, T., Komatsu, M., Okada, N., and Yamada, T. (1992) Diabetes 41, 438-443[Abstract]
33. Rustenbeck, I., Herrmann, C., and Grimmsmann, T. (1997) Diabetes 46, 1305-1311[Abstract]
34. Sutton, R., Peters, M., and McShane, P. (1986) Transplantation 42, 689-691[Medline] [Order article via Infotrieve]
35. Misler, S., Falke, L. C., Gillis, K., and McDaniel, L. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 7119-7123[Abstract/Free Full Text]
36. Hamill, O. P., Marty, A., Neher, E., Sakmann, B., and Sigworth, F. J. (1981) Pflügers Arch. 391, 85-100[CrossRef][Medline] [Order article via Infotrieve]
37. Suga, S., Kanno, T., Nakano, K., Takeo, T., Dobashi, Y., and Wakui, M. (1997) Diabetes 46, 1755-1760[Abstract]
38. Levitan, E. S., and Kramer, R. H. (1990) Nature 348, 545-548[CrossRef][Medline] [Order article via Infotrieve]
39. Sala, S., Parsey, R. V., Cohen, A. S., and Matteson, D. R. (1991) J. Membr. Biol. 122, 177-187[CrossRef][Medline] [Order article via Infotrieve]
40. Malaisse, W. J., and Sener, A. (1987) Biochim. Biophys. Acta 927, 190-195[Medline] [Order article via Infotrieve]
41. Gribble, F., Tucker, S., and Ashcroft, F. M. (1997) EMBO J. 16, 1145-1152[CrossRef][Medline] [Order article via Infotrieve]
42. Gembal, M., Detimary, P., Gilon, P., Gao, Z. Y., and Henquin, J. C. (1993) J. Clin. Invest. 91, 871-880
43. Aizawa, T., Sato, Y., Ishihara, F., Taguchi, N., Komatsu, M., Suzuki, N., Hashizume, K., and Yamada, T. (1994) Am. J. Physiol. 266, C622-C627[Abstract/Free Full Text]
44. Ashcroft, F. M. (1988) Annu. Rev. Neurosci. 11, 97-118[CrossRef][Medline] [Order article via Infotrieve]
45. Inagaki, N., Gonoi, T., Clement, J. P., IV, Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., and Bryan, J. (1995) Science 270, 1166-1170[Abstract/Free Full Text]
46. Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., IV, Boyd, A. E., III, Gonzalez, G., Herrera-Sosa, H., Nguy, K., Bryan, J., and Nelson, D. A. (1995) Science 268, 423-426[Abstract/Free Full Text]
47. Shyng, S., Ferrigni, T., and Nichols, C. (1997) J. Gen. Physiol. 110, 141-153[Abstract/Free Full Text]
48. Tucker, S., Gribble, F., Zhao, C., Trapp, S., and Ashcroft, F. M. (1997) Nature 387, 179-183[CrossRef][Medline] [Order article via Infotrieve]
49. Nichols, C. G., Shyng, S. L., Nestorowicz, A., Glaser, B., Clement, J. P., IV, Gonzalez, G., Aguilar-Bryan, L., Permutt, M. A., and Bryan, J. (1996) Science 272, 1785-1787[Abstract]
50. Shyng, S., Ferrigni, T., and Nichols, C. (1997) J. Gen. Physiol. 110, 643-654[Abstract/Free Full Text]
51. Niki, I., and Ashcroft, S. J. H. (1991) Biochim. Biophys. Acta 1133, 95-101[Medline] [Order article via Infotrieve]
52. Ashcroft, F. M. (1996) Horm. Metab. Res. 28, 456-463[Medline] [Order article via Infotrieve]
53. Ohta, M., Nelson, D., Nelson, J., Meglasson, M. D., and Erecinska, M. (1990) J. Biol. Chem. 265, 17525-17532[Abstract/Free Full Text]
54. Regazzi, R., Wollheim, C. B., Lang, J., Theler, J. M., Rossetto, O., Montecucco, C., Sadoul, K., Weller, U., Palmer, M., and Thorens, B. (1995) EMBO J. 14, 2723-2730[Medline] [Order article via Infotrieve]
55. Takahashi, N., Kadowaki, T., Yazaki, Y., Ellis-Davies, G. C. R., Miyashita, Y., and Kasai, H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 760-765[Abstract/Free Full Text]
56. Hamakawa, N., and Yada, T. (1995) Cell Calcium 17, 21-31[CrossRef][Medline] [Order article via Infotrieve]
57. Schuit, F. C. (1996) Horm. Res. (Basel) 46, 99-106[Medline] [Order article via Infotrieve]
58. de Vargas, L. M., Sobolewski, J., Siegel, R., and Moss, L. G. (1997) J. Biol. Chem. 272, 26573-26577[Abstract/Free Full Text]
59. Trube, G., Rorsman, P., and Ohno-Shosaku, T. (1986) Pflügers Arch. 407, 493-499[CrossRef][Medline] [Order article via Infotrieve]
60. Bergsten, P., Gylfe, E., Wesslen, N., and Hellman, B. (1988) Am. J. Physiol. 255, E422-E427[Abstract/Free Full Text]
61. Sato, Y., and Henquin, J.-C. (1998) Diabetes 47, 1713-1721[Abstract]
62. Dukes, I. D., Sreenan, S., Roe, M. W., Levisetti, M., Zhou, Y.-P., Ostrega, D., Bell, G. I., Pontoglio, M., Yaniv, M., Philipson, L., and Polonsky, K. S. (1998) J. Biol. Chem. 273, 24457-24464[Abstract/Free Full Text]
63. Wang, H., Maechler, P., Hagenfeldt, K. A., and Wollheim, C. B. (1998) EMBO. J. 17, 6701-6713[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Polakof, J. M. Miguez, and J. L. Soengas
In vitro evidences for glucosensing capacity and mechanisms in hypothalamus, hindbrain, and Brockmann bodies of rainbow trout
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1410 - R1420.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. A. Martens, Q. Wang, K. Kerckhofs, G. Stange, Z. Ling, and D. Pipeleers
Metabolic Activation of Glucose Low-Responsive {beta}-Cells by Glyceraldehyde Correlates with Their Biosynthetic Activation in Lower Glucose Concentration Range But Not at High Glucose
Endocrinology, November 1, 2006; 147(11): 5196 - 5204.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Merglen, S. Theander, B. Rubi, G. Chaffard, C. B. Wollheim, and P. Maechler
Glucose Sensitivity and Metabolism-Secretion Coupling Studied during Two-Year Continuous Culture in INS-1E Insulinoma Cells
Endocrinology, February 1, 2004; 145(2): 667 - 678.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Yamada, M. Komatsu, Y. Sato, K. Yamauchi, T. Aizawa, and I. Kojima
Nutrient Modulation of Palmitoylated 24-Kilodalton Protein in Rat Pancreatic Islets
Endocrinology, December 1, 2003; 144(12): 5232 - 5241.
[Abstract] [Full Text]